Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis
Author(s) -
Rodrigo F. Rodrigues,
Carlos R. Zárate-Bladés,
Wendy Martin Rios,
Luana Silva Soares,
Patricia Souza,
Izaíra Tincani Brandão,
Ana Paula Masson,
Frederico G. C. Arnoldi,
Simone G. Ramos,
Franck Letourneur,
Sébastien Jacques,
Nicolas Cagnard,
Gilles Chiocchia,
Célio Lopes Silva
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv023
Subject(s) - immunotherapy , tuberculosis , chemotherapy , genome , immunology , medicine , biology , virology , immune system , genetics , pathology , gene
Although TB immunotherapy improves the results of conventional drug treatment, the effects of combining chemotherapy and immunotherapy have never been systematically evaluated. We used a comprehensive lung transcriptome analysis to directly compare the activity of combined chemotherapy and immunotherapy with that of single treatments in a mouse model of TB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom